Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-24-188900
Filing Date
2024-07-30
Accepted
2024-07-30 16:19:55
Documents
1
Effectiveness Date
2024-07-30

Document Format Files

Seq Description Document Type Size
1 15-12G d873840d1512g.htm 15-12G 10126
  Complete submission text file 0001193125-24-188900.txt   11291
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-39866 | Film No.: 241157736
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)